Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
Condition(s):COVID-19; Coronavirus InfectionsLast Updated:April 4, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):COVID-19; Coronavirus InfectionsLast Updated:April 4, 2023Withdrawn
Condition(s):Patients With Cancers; COVID-19; VaccineLast Updated:June 27, 2023Recruiting
Condition(s):Coronavirus Disease 2019 Vaccines; Renal DialysisLast Updated:August 5, 2022Completed
Condition(s):Coronavirus Infection; COVID-19Last Updated:January 30, 2023Terminated
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:August 16, 2023Active, not recruiting
Condition(s):Covid19Last Updated:June 14, 2021Completed
Condition(s):Coronavirus Infection COVID-19Last Updated:February 2, 2022Completed
Condition(s):Depression and Quality of Life Related to the Coronavirus PandemicLast Updated:January 19, 2022Completed
Condition(s):CoronavirusLast Updated:December 3, 2020Unknown status
Condition(s):Toxicity by BleachLast Updated:November 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.